Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05998109 · ClinicalTrials.gov registry record
PheCheck Feasibility Study
A clinical trial of Phenylketonurias, sponsored by Lumos Diagnostics.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05998109 is a study of Phenylketonurias that has completed, run by Lumos Diagnostics. The registered enrollment target is 30 participants, below the 40-participant average among 5 other Phenylketonurias trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05998109, a study of Phenylketonurias, has completed, sponsored by Lumos Diagnostics.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this feasibility study clinical trial is to compare the accuracy of PheCheck™ for the rapid quantitative detection of phenylalanine (Phe) with the gold standard (HPLC amino acid analyzer), in patients with PKU. The main aims are: * Evaluate the accuracy of PheCheck as compared to the gold standard * Evaluate ease of use by lay participants
Conditions Studied
Interventions
- DEVICE PheCheck™
- DIAGNOSTIC_TEST HPLC Amino Acid Analyzer
- DIAGNOSTIC_TEST Dried Blood Spot Cards
Study Locations (1)
Pennsylvania
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-12-15 |
| Est. Completion | 2024-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05998109
The ClinicalTrials.gov registry entry for NCT05998109 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 40-participant average among 5 other Phenylketonurias trials with a reported enrollment target (25% lower). The listed sponsor is Lumos Diagnostics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Phenylketonurias appearing as the primary indexed condition, and to 3 interventions - of which PheCheck™ is the first listed.
NCT05998109 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05998109 about?
NCT05998109 is a clinical study titled "PheCheck Feasibility Study". The goal of this feasibility study clinical trial is to compare the accuracy of PheCheck™ for the rapid quantitative detection of phenylalanine (Phe) with the gold standard (HPLC amino acid analyzer), in patients with PKU. The main aims are: * Evaluate the accuracy of PheCheck as compared to the g...
What is the current status of trial NCT05998109?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2023-12-15. Estimated completion is 2024-07-31.
What conditions does trial NCT05998109 study?
This clinical trial studies the following conditions: Phenylketonurias.
What interventions are being tested in trial NCT05998109?
The interventions under investigation include: PheCheck™ (DEVICE), HPLC Amino Acid Analyzer (DIAGNOSTIC_TEST), Dried Blood Spot Cards (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05998109?
This trial is sponsored by Lumos Diagnostics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05998109 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phenylketonurias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)
RECRUITING · Phase 1
-
Development of Novel Psychological Assessment Tools and Anxiety Intervention for Phenylketonuria
RECRUITING · NA
-
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
RECRUITING
-
Remote Neurocognitive and Psychological Assessment in PKU
COMPLETED
-
Bone Mineral Density in Adults With Hyperphenylalaninemia
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.